2m 2m 2m 2m 2m 2m 2m
Abbott Laborator (ABT)
NYSE
$97.25+$0.56 (+0.58%)
Price as of Oct 02, 2026 3:36 PM EDT- $167.3BMarket Cap
- -25.61%1-Year Change
- Medical DevicesIndustry
Abbott Laborator (ABT)
$97.25+$0.56 (+0.58%)
ABT | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $96.69 | ||
Change | -$2.14 (-2.17%) | ||
Open | $99.10 | ||
High | $99.44 | ||
Low | $96.54 | ||
Previous Close | $98.83 | ||
Volume | 8,862,347 | ||
30-Day Average Volume | 8,589,204 | ||
1-Week Change | -4.33% | ||
1-Month Change | -11.24% | ||
1-Year Change | -25.61% | ||
3-Year Change | 6.27% | ||
5-Year Change | -9.08% | ||
Fundamentals | |||
Shares Outstanding | 1.7B | ||
Total Assets | $109.2B | ||
Market Cap | $167.3B | ||
Enterprise Value | $194.8B | ||
Period: QTR TTM FY | |||
Revenue | $12.6B | ||
Net Income | $928.0M | ||
Free Cash Flow | $2.0B | ||
EBIT | $1.8B | ||
EBITDA | $2.5B | ||
Net Working Capital | $6.7B | ||
EPS | $0.53 | ||
Enterprise Value/EBITDA | 79 | ||
Enterprise Value/Revenue | 15 | ||
P/B | 3 | ||
P/E | 182 | ||
PEG | -14 | ||
Price/Free Cash Flow | 84 | ||
Price/Operating Cash Flow | 67 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | 2.61% | ||
Trailing Annual Dividend Yield | 2.56% | ||
Ex-Dividend Date | 10/15/2026 | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue
Annual Dividend Yield